Emory University: Clinical Trials

180 trials sponsored by Emory University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

117 completed, 24 terminated, 20 recruiting, 11 withdrawn. 180 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4180Completed 117, Terminated 24, Recruiting 20, Withdrawn 11, Active not recruiting 3, Not yet recruiting 2, Enrolling by invitation 1, Suspended 1, Unknown 1

Follow Emory University: new trials by email

Trials (filtered) newest first · largest first

All 180 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The EMBRACE Study: Enflonsia Monoclonal in Babies - RSV Antibody Concentration Evaluation
Clesrovimab - RSV Infection
Phase 4Not yet recruitingEmory University242026-09-012026-09-17
Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease
Prophylactic Transfusion Intervention group: Transfusion, Control group - Sickle Cell Disease, Pregnancy Related
Phase 4WithdrawnEmory University2026-09-012026-10-19
Role of Suzetrigine as a Part of a Multimodal Regimen to Reduce Pain and Opioid Use After Total Knee Arthroplasty
Suzetrigine - Knee Arthritis, Knee Osteoarthritis
Phase 4Not yet recruitingEmory University752026-07-012026-06-03
Comprehensive Toileting Program
Glycerin Suppository, Behavioral strategies - Encopresis, ASD
Phase 4RecruitingEmory University1502026-06-012026-06-18
MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults
Trumenba, PENBRAYA - Neisseria Meningitidis
Phase 4RecruitingEmory University1252025-11-042025-12-22
Systems Biological Analysis of Immune Responses to RSV Vaccine
Moderna RSV vaccine - Respiratory Syncytial Virus (RSV)
Phase 4Active not recruitingEmory University142025-10-132026-08-12
Got Doxy- 'Flipping the Script' on STI PEP
Doxycycline monohydrate 200 mg, Observation - Sexually Transmitted Infections (STI)
Phase 4RecruitingEmory University2002025-10-132026-04-30
Safety of RSV Preventive Monoclonal Antibody
Respiratory Syncytial Virus (RSV) Preventive Monoclonal Antibody - Fever, Adverse Event Following Immunisation
Phase 4RecruitingDuke University5242025-10-022026-03-16
Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial
Acetaminophen, Biospecimen Collection, Dexamethasone - Multiple Myeloma
Phase 4RecruitingEmory University942025-09-242026-07-23
HPV Vaccine Reduced Dose
Gardasil-9, Lidocaine injection, Lorazepam - HPV
Phase 4RecruitingEmory University1002025-08-062026-08-31
Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases
Moxidectin, Ivermectin - Onchocerciasis, Ascaris Lumbricoides Infection
Phase 4RecruitingKirby Institute520002025-08-042025-11-21
Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease
Depot medroxyprogesterone acetate (DMPA) - Sickle Cell Disease (SCD), Vaso-Occlusive Pain Episode in Sickle Cell Disease
Phase 4RecruitingUniversity of Pennsylvania652025-06-262026-05-28
Trachoma Elimination Study by Focused Antibiotic (TESFA)
Azithromycin mass treatment, Azithromycin targeted treatment - Trachoma
Phase 4WithdrawnEmory University2025-06-012025-07-16
Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity
Continuous Glucose Monitoring, Insulin - Ketosis Prone Diabetes
Phase 4RecruitingEmory University122025-01-232026-06-15
Antihypertensive Mechanisms of Minocycline in Resistant Hypertension
Minocycline Hydrochloride, Placebo - Hypertension, Resistant to Conventional Therapy
Phase 4RecruitingUniversity of Florida1202025-01-082026-10-13
Revealing Protective Immunity to Influenza Using Systems Immunology
Live Attenuated Influenza Vaccine - Influenza
Phase 4CompletedEmory University512024-10-142026-03-30
Daily Doxycycline to Inform Sexually Transmitted Infection Prophylaxis Regimens
Doxycycline - Sexually Transmitted Infection
Phase 4CompletedEmory University242024-09-132026-05-01
Chronic Exertional Compartment Syndrome (CECS) Treated With Abobotulinumtoxin A
AbobotulinumtoxinA, Placebo - Compartment Syndrome of Leg
Phase 4CompletedEmory University32024-04-252025-10-21
Anti-Inflammatory Challenge in Schizophrenia
Infliximab, Placebo - Schizophrenia
Phase 4RecruitingEmory University602024-04-182026-06-03
Concentrated Bone Marrow Aspirate in Revision ACL Reconstruction
Concentrated Bone Marrow Aspirate Injection, Sham Incision, Revision Anterior Cruciate Ligament Reconstruction - Anterior Cruciate Ligament Injuries, Post-Traumatic Osteoarthritis of Knee
Phase 4RecruitingHospital for Special Surgery, New York402024-01-222025-11-20

Showing 20 of 180. Sign in to see all of them.

Conditions studied

Depression (16)  ·  Diabetes Mellitus (15)  ·  Diabetes Mellitus, Type 2 (15)  ·  Depressive Disorder, Major (7)  ·  Hyperglycemia (7)  ·  Inflammation (5)  ·  Influenza, Human (5)  ·  Sexually Transmitted Diseases (5)  ·  Stress Disorders, Post-Traumatic (5)  ·  Acquired Immunodeficiency Syndrome (4)  ·  Agnosia (4)  ·  Cognitive Dysfunction (4)  ·  Hypertension (4)  ·  Pain (4)  ·  Psychotic Disorders (4)

Interventions

Insulin Glargine (17)  ·  Insulin Aspart (11)  ·  Insulin (9)  ·  Insulin Lispro (9)  ·  Escitalopram (7)  ·  Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (6)  ·  Saline Solution (6)  ·  Bupivacaine (5)  ·  Doxycycline (5)  ·  Infliximab (5)  ·  Lidocaine (5)  ·  Sitagliptin Phosphate (5)  ·  Standard of Care (5)  ·  Calcium Dobesilate (4)  ·  Cholecalciferol (4)

Countries

United States (167)  ·  Angola (1)  ·  Brazil (1)  ·  Canada (1)  ·  Israel (1)  ·  Kenya (1)  ·  Mexico (1)  ·  Mozambique (1)  ·  South Sudan (1)

Top investigators

Guillermo Umpierrez, MD (11)  ·  Nadine Rouphael, MD (6)  ·  Colleen Kelley, MD, MPH (5)  ·  Guillermo E Umpierrez, MD (3)  ·  Igho Ofotokun, MD, MSc (3)  ·  Jennifer Felger, PhD (3)  ·  John Xerogeanes, MD (3)  ·  Ajay Premkumar, MD (2)  ·  Andrew H Miller, MD (2)  ·  Andrew Miller, MD (2)  ·  Christina Rostad, MD (2)  ·  Laura Gilbertson, MD (2)  ·  Maya Fayfman, MD (2)  ·  Philip T Ninan, MD (2)  ·  Qiang Cai, MD, PhD (2)

Results publications

PMID 41701614, PMID 19366972, PMID 30524702, PMID 11587154, PMID 12748199, PMID 12791627, PMID 14717616, PMID 1550069, PMID 17496462, PMID 17513708, PMID 17615254, PMID 17920917, PMID 18292756, PMID 18378867, PMID 19017758, PMID 19171788, PMID 19225527, PMID 19933869, PMID 20854139, PMID 21079049, PMID 21179973, PMID 21228246, PMID 21368772, PMID 22353759, PMID 22364141, PMID 22399505, PMID 22805498, PMID 22945416, PMID 22964160, PMID 23039824, PMID 23280269, PMID 23575741, PMID 23624296, PMID 23741398, PMID 23877988, PMID 24336012, PMID 24373307, PMID 25271011, PMID 25529904, PMID 25681236, PMID 25782693, PMID 26122686, PMID 26285691, PMID 26482774, PMID 26811165, PMID 26865594, PMID 26903303, PMID 27159290, PMID 27632067, PMID 27632069

NIH funding

P30CA138292 (2), R01MH109320 (2), 1RC3NS070646-01 (1), K23AI124913 (1), K23DK122199 (1), K23DK124647 (1), K23DK131317 (1), K23GM128221 (1), P50NS123103 (1), R01AG028769 (1), R01AI192319 (1), R01ES025775 (1), R01HD115933 (1), R01HL065523 (1), R01HL132448 (1)